BioMarin Pharmaceuticals, Inc. (BMRN) Reports Q4 Loss of 11c/sh

February 26, 2014 4:20 PM

BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) reported Q4 EPS of ($0.11),may ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found